Economic Analysis of Pharmacological Interventions for Substance Use Disorders Cost-Effectiveness and Market Dynamics
Author(s): Kurmala Ganga Raju, P. Varaprasad Goud, Shagufta Parween, M. Ramarao, T.S. Leelavati, S. Madhavi and Shaik Aminabee*
Abstract
This study conducts an economic analysis of pharmacological interventions for Substance Use Disorders (SUDs), focusing on cost-effectiveness and market dynamics. Substance abuse remains a significant public health concern, with substantial economic and social costs. Pharmacotherapy plays a crucial role in the treatment of SUDs, yet economic considerations and market factors influence the accessibility and adoption of these interventions. Through a comprehensive review of existing literature, this paper evaluates the cost-effectiveness of pharmacological treatments for various substance dependencies and examines the market dynamics shaping their implementation. Factors such as drug pricing, reimbursement policies, healthcare financing, and market competition are analyzed to understand their impact on the availability and affordability of pharmacological interventions for SUDs. The findings provide insights into the economic implications of different treatment approaches and offer recommendations for optimizing the cost-effectiveness and accessibility of pharmacotherapy in addressing substance abuse.
